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Abstract
© 2016, Springer Science+Business Media New York.Inhibition of serotonin uptake disrupts the
development of thalamocortical barrel maps in neonatal rodents. Previous studies, using the
selective  serotonin  reuptake  inhibitor  citalopram,  have  suggested  that  this  may involve  a
suppression of the early activity in the developing cortex. Here, we addressed the acute effects
of  another  frequently  used  serotonin  uptake  inhibitor,  fluoxetine  (10–120  mg/kg,
intraperitoneally), on the sensory-evoked electrical responses in the neonatal (postnatal days
P2-6) rat barrel cortex. We found that the administration of fluoxetine minimally affected the
sensory-evoked responses in the rat pups. Two hours after the fluoxetine administration, there
was a slight increase in the sensory-evoked potential (SEP) onset latency. There also was a
tendency of SEP’s amplitude to decrease, but this was not significant. Fluoxetine also had no
significant effect on the multiple unit activity during the SEP and sensory-evoked bursts and
neither did it affect the spontaneous multiple unit activity. We suggest that the inhibitory effects
of fluoxetine on the activity in the neonatal rat barrel cortex are much weaker, or that they
develop over a slower time scale, than those evoked by citalopram, probably reflecting a lower
potency of fluoxetine to inhibit the serotonin uptake.
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